D.E. Shaw & Co’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$366K Buy
+20,556
New +$366K ﹤0.01% 2630
2025
Q1
Sell
-185,303
Closed -$5.52M 3242
2024
Q4
$5.52M Sell
185,303
-465,011
-72% -$13.9M ﹤0.01% 1248
2024
Q3
$10.2M Sell
650,314
-48,980
-7% -$766K 0.01% 944
2024
Q2
$12M Sell
699,294
-254,618
-27% -$4.36M 0.01% 825
2024
Q1
$14.9M Sell
953,912
-411,405
-30% -$6.43M 0.01% 733
2023
Q4
$20.4M Buy
1,365,317
+1,013,867
+288% +$15.1M 0.02% 560
2023
Q3
$5.68M Buy
351,450
+295,866
+532% +$4.78M 0.01% 1119
2023
Q2
$2.31M Buy
55,584
+22,567
+68% +$937K ﹤0.01% 1675
2023
Q1
$1.99M Buy
33,017
+15,017
+83% +$903K ﹤0.01% 1868
2022
Q4
$1.32M Buy
18,000
+6,697
+59% +$491K ﹤0.01% 2269
2022
Q3
$859K Buy
11,303
+4,689
+71% +$356K ﹤0.01% 2622
2022
Q2
$460K Buy
+6,614
New +$460K ﹤0.01% 3074
2022
Q1
Hold
0
4412
2021
Q4
Sell
-85,016
Closed -$9.88M 4134
2021
Q3
$9.88M Sell
85,016
-65,085
-43% -$7.56M 0.01% 1047
2021
Q2
$33.3M Buy
150,101
+15,185
+11% +$3.37M 0.03% 526
2021
Q1
$17.8M Buy
134,916
+91,350
+210% +$12.1M 0.02% 744
2020
Q4
$7.54M Buy
43,566
+11,787
+37% +$2.04M 0.01% 1095
2020
Q3
$3.54M Buy
31,779
+14,743
+87% +$1.64M ﹤0.01% 1363
2020
Q2
$1.01M Sell
17,036
-31,885
-65% -$1.89M ﹤0.01% 1905
2020
Q1
$3.29M Sell
48,921
-57,392
-54% -$3.86M 0.01% 1268
2019
Q4
$8.96M Sell
106,313
-109,707
-51% -$9.25M 0.01% 890
2019
Q3
$16.2M Sell
216,020
-331,355
-61% -$24.8M 0.02% 643
2019
Q2
$34.6M Sell
547,375
-109,506
-17% -$6.92M 0.04% 394
2019
Q1
$31.6M Buy
656,881
+614,012
+1,432% +$29.6M 0.04% 406
2018
Q4
$1.44M Buy
+42,869
New +$1.44M ﹤0.01% 1693
2018
Q2
Sell
-50,206
Closed -$1.09M 2666
2018
Q1
$1.09M Sell
50,206
-15,719
-24% -$343K ﹤0.01% 1770
2017
Q4
$1.33M Buy
+65,925
New +$1.33M ﹤0.01% 1713
2017
Q3
Sell
-30,589
Closed -$529K 2568
2017
Q2
$529K Buy
30,589
+18,672
+157% +$323K ﹤0.01% 1965
2017
Q1
$97K Sell
11,917
-25,339
-68% -$206K ﹤0.01% 2343
2016
Q4
$292K Buy
+37,256
New +$292K ﹤0.01% 2230